These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7405222)

  • 1. [Desmofibrinogenic activity and plasma thiol group concentration in systemic lupus erythematosus].
    Zuch A; Pietruska Z
    Wiad Lek; 1980 Apr; 33(8):601-5. PubMed ID: 7405222
    [No Abstract]   [Full Text] [Related]  

  • 2. [Desmofibrinogenic activity of factor XIII and plasma concentration of thiol groups in the course of systemic scleroderma].
    Zuch A; Pietruska Z; Bogdanikowa B; Buluk K
    Reumatologia; 1979; 17(4):457-63. PubMed ID: 531372
    [No Abstract]   [Full Text] [Related]  

  • 3. [Desmofibrinogenic activity of factor XIII and thiol group levels of the plasma of patients with rheumatoid arthritis treated with levamisole].
    Zarzycka B; Pietruska Z; Górska M
    Pol Tyg Lek; 1983 Feb; 38(7):209-12. PubMed ID: 6866835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impairment of the desmofibrinogenic activity of the fibrin stabilizing factor (FSF) due to free thiol group (SH) deficiency in middle-aged and old persons].
    Zuch A; Buluk K
    Acta Haematol Pol; 1980; 11(3):129-35. PubMed ID: 7445918
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Von Willebrand factor in plasma of patients with rheumatoid arthritis and lupus erythematosus].
    Paczuski R; Iwan-Zietek I; Kotschy M; Bielawska J; Sadkiewicz S
    Pol Merkur Lekarski; 1998 May; 4(23):254-6. PubMed ID: 9825655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Desmofibrinogenesis impairment during neoplastic process].
    Zuch A; Buluk K
    Patol Pol; 1980; 31(3):351-6. PubMed ID: 7220115
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant?
    Ames PR; Alves J; Pap AF; Ramos P; Khamashta MA; Hughes GR
    J Rheumatol; 2000 May; 27(5):1190-5. PubMed ID: 10813286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of fibrinopeptide A in the control of systemic lupus erythematosus].
    Font J; Casals A; Bové A; Guerrero A; Ingelmo M; Balcells A
    Rev Clin Esp; 1986 Mar; 178(4):203-4. PubMed ID: 3715128
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of desmofibrinogenic activity and FSF (factor XIII of blood coagulation) level in plasma of healthy children in various age groups].
    Zuch A; Zwierzowa W; Rudobielska M; Buluk K
    Pediatr Pol; 1972 Oct; 47(10):1205-11. PubMed ID: 5085406
    [No Abstract]   [Full Text] [Related]  

  • 11. Abnormal plasma and serum viscosity in systemic lupus erythematosus (SLE): a Jamaican study.
    Reid HL; De Ceulaer K
    Clin Hemorheol Microcirc; 1999; 20(3):175-80. PubMed ID: 10463841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an acquired IgG inhibitor of coagulation factor XIII in a patient with systemic lupus erythematosus.
    Ahmad F; Solymoss S; Poon MC; Berube C; Sullivan AK
    Br J Haematol; 1996 Jun; 93(3):700-3. PubMed ID: 8652397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenomedullin--a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus.
    Mak A; Cheung BM; Mok CC; Leung R; Lau CS
    Rheumatology (Oxford); 2006 Oct; 45(10):1266-72. PubMed ID: 16595522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
    Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
    Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarographic study of serum from patients with lupus erythematosus.
    Ogura RM; Owens DW; Knox JM
    Dermatologica; 1967; 135(2):181-6. PubMed ID: 6052547
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet and plasma serotonin in glomerulonephritis. III: The nephritis of systemic lupus erythematosus.
    Parbtani A; Frampton G; Yewdall V; Kasai N; Cameron JS
    Clin Nephrol; 1980 Oct; 14(4):164-72. PubMed ID: 7428190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
    Kiss E; Fazekas B; Tarr T; Muszbek L; Zeher M; Szegedi G
    Orv Hetil; 2004 Feb; 145(5):217-22. PubMed ID: 15024932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between prolactin levels and clinical activity in patients with systemic lupus erythematosus.
    Mok CC; Lau CS
    J Rheumatol; 1996 Dec; 23(12):2185-6. PubMed ID: 8970067
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormonal changes in fertile women with quiescent systemic lupus erythematosus].
    Benito Urbina S; Huarte Loza E; Gijón Baños J; Arnalich-Fernández F
    An Med Interna; 1995 May; 12(5):221-4. PubMed ID: 7669873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional Ser(413)/Ser(413) PAI-2 polymorphism is associated with susceptibility and damage index score in systemic lupus erythematosus.
    Palafox-Sánchez CA; Vázquez-Del Mercado M; Orozco-Barocio G; García-De la Torre I; Torres-Carrillo N; Torres-Carrillo NM; Illades-Aguiar B; Muñoz-Valle JF
    Clin Appl Thromb Hemost; 2009; 15(2):233-8. PubMed ID: 18818228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.